Precision Health
Sept 8–10, 2022
San Diego, CA
Bringing together leading genomic researchers, healthcare professionals, and healthcare industry stakeholders to usher in a new era of precision medicine.


As AGBT Precision Health enters our 7th year we continue to focus on technologies, implementation, and major research breakthroughs.

Over the last several years, this meeting has highlighted the most provocative discoveries and major initiatives in genomic medicine from leaders of national healthcare systems, genomics institutes, international biobank initiatives, transformative diagnostic approaches, and hospital-based implementation and reimbursement. Continuing the historical focus of AGBT on technologies and public-private partnerships, the Precision Health Meeting highlights innovative technologies and their impact in clinical diagnostics and therapeutic development, as well as the evolving view of genotype-phenotype interpretation from rare variants to polygenic risk scores.

This event is for leading genomic researchers, healthcare professionals, and healthcare industry stakeholders. We bring together practitioners and innovators at the interface of genomics, medicine, and health to usher in a new era of precision medicine. Our aim is to pass the torch from pioneering researchers and developers of genome technologies to first movers in healthcare who are establishing standards of care and cutting-edge applications for genome technology in everyday clinical practice.




Universities and Governments





(In person meetings have averaged 350 attendees)
Graphic below shows-VIRTUAL 2020 DEMOGRAPHICS

Attend AGBT’s Precision Health meeting focusing on technologies, implementation, and major research breakthroughs.


This was the best conference I have ever attended. The talks were stellar and I really enjoyed the small size relative to the larger meetings I typically attend…it was more personalized and meaningful.

AGBT Precision Health Attendee

The caliber of talks was unrelenting…nothing short of stellar!

AGBT Precision Health Attendee

I enjoyed learning how the rest of the field is thinking about genomic testing (i.e. combining WGS and RNAseq) The scientific content was excellent and I made a lot of new connections. 

 AGBT Precision Health Attendee

Very distinguished series of speakers from diverse clinical fields and perspectives with common genomic thread. Best collection of talks I’ve seen at a conference lately.

AGBT Precision Health Attendee


Michael Berger

Michael Berger, PhD, is an Associate Director of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology at Memorial Sloan Kettering Cancer Center, a multidisciplinary initiative to promote precision oncology through genomic analysis to guide the diagnosis and treatment of cancer patients. He is also an Associate Attending Geneticist in the Department of Pathology […]


Penelope Bonnen

As an Associate Professor at Baylor College of Medicine, Dr. Bonnen is applying her acumen in bioinformatics and human genetics to gene discovery studies for an array of phenotypes and diseases including disorders caused by mitochondrial dysfunction and cancer. The Bonnen lab develops and applies methods for analyzing next-generation sequence data and interpretation of human […]


Wendy Chung

Wendy Chung, M.D., Ph.D. is a clinical and molecular geneticist and the Kennedy Family Professor of Pediatrics and Medicine and director of clinical genetics at Columbia University. She received her B.A. in biochemistry and economics from Cornell University, her M.D. from Cornell University Medical College, and her Ph.D. in genetics from The Rockefeller University. Dr. Chung […]


Geoffery S Ginsburg

Geoffrey Ginsburg, M.D., Ph.D., is the Chief Medical and Scientific Officer of the All of Us Research Program at the National Institutes of Health. He leads the Division of Medical and Scientific Research and is responsible for helping to set the scientific vision and strategy for the program. He also oversees the program’s collection and curation of data, and […]


Eric D. Green

Dr. Eric Green is the Director of the National Human Genome Research Institute (NHGRI) at the U.S. National Institutes of Health (NIH). He is the third NHGRI Director, having been appointed by NIH Director Dr. Francis Collins in 2009. Dr. Green has been at the Institute for more than 25 years, during which he has […]


Stephen F. Kingsmore

Stephen F. Kingsmore is President/CEO of the Rady Children’s Institute for Genomic Medicine, San Diego, which is implementing pediatric genomic medicine on an unprecedented scale. Previously he was the Dee Lyons/Missouri Endowed Chair in Genomic Medicine at the Univ. of Missouri-Kansas City School of Medicine and Director of the Center for Pediatric Genomic Medicine at […]


Howard McLeod

Dr Howard McLeod is an internationally recognized expert in precision medicine, having made novel contributions at the discovery, translation, implementation, and policy levels.  He is the Medical Director for Precision Medicine at the Geriatric Oncology Consortium and a Professor at the University of South Florida Taneja College of Pharmacy.  Howard received a BSPharm from University […]


Len Pennacchio

Dr. Len Pennacchio is a Senior Scientist at the Lawrence Berkeley Laboratory (LBL), Deputy Director of the DOE Joint Genome Institute, and Adjunct Professor at the University of California Berkeley.  He received his PhD in Genetics from Stanford University in 1998 under Rick Myers and then served as a DOE Alexander Hollaender Distinguished Fellow at […]

A white woman with short brown hair--wearing a silver jacket, a pendant necklace, and a small smile--looks directly into the camera. She is on the right side of the frame, in front of a blurred wood and stone background.

Kathryn A. Phillips

Kathryn A. Phillips, PhD, is Professor of Health Economics and Health Services Research at the University of California San Francisco. She founded and leads the UCSF Center for Translational and Policy Research on Precision Medicine (TRANSPERS), which focuses on developing objective evidence on how to implement precision medicine into health care so that it is effective, efficient, […]


Heidi L. Rehm

Heidi L. Rehm, PhD, FACMG is a board-certified clinical laboratory geneticist and genomic medicine researcher. She is the Chief Laboratory Director at the Partners Laboratory for Molecular Medicine, the Medical Director of the Broad Institute Clinical Research Sequencing Platform and Associate Professor of Pathology at Brigham & Women’s Hospital and Harvard Medical School. She is […]


Michael E. Talkowski

Dr. Talkowski directs a genomics research program that explores the consequences of genetic variation on human disease, particularly human developmental and neuropsychiatric disorders, as well as the application of innovations in genomics technology to clinical diagnostics.  Dr. Talkowski has performed seminal studies to introduce high-resolution genomics techniques to delineate the types of genetic variation that […]


The Genome Partnership convenes the world’s most revered genome science and technology conferences, bringing together top global researchers, leaders, and innovators in human health and agriculture. The Genome Partnership has been proudly organizing The Advances in Genome Biology and Technology (AGBT) meetings since 1999. The Genome Partnership, based in St. Louis, is a not-for-profit organization and its mission is to advance research, promote education, and expand commerce in genome science and technology. For more information visit